IFN-γ, effector cytokines of T cells, can directly exert an effective antitumor immune response by recognizing the corresponding receptors on tumor cells or indirectly promote the cross-activation of CD8+ T cells by upregulating antigen-presenting machinery to attack tumor cells (163). This evidence concerns the gene CD8A and neoplasm.